Related references
Note: Only part of the references are listed.Selective Forms of Therapy in the Treatment of Inflammatory Bowel Diseases
Anna Kofla-Dlubacz et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Intestinal outcome of bone marrow transplantation for monogenic inflammatory bowel disease
Mari Morita et al.
PEDIATRICS INTERNATIONAL (2022)
Increasing Prevalence and Stable Incidence Rates of Inflammatory Bowel Disease Among First Nations: Population-Based Evidence From a Western Canadian Province
Juan Nicolas Pena-Sanchez et al.
INFLAMMATORY BOWEL DISEASES (2022)
Muc2 Mucin and Nonmucin Microbiota Confer Distinct Innate Host Defense in Disease Susceptibility and Colonic Injury
Aralia Leon-Coria et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2021)
The Incidence of Inflammatory Bowel Disease in the Paediatric Population in the District of Lower Silesia, Poland
Elzbieta Krzesiek et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Rare minisatellite alleles of MUC2-MS8 influence susceptibility to rectal carcinoma
So-Young Seol et al.
GENES & GENOMICS (2021)
Changing Global Epidemiology of Inflammatory Bowel Diseases: Sustaining Health Care Delivery Into the 21st Century
Ashwin N. Ananthakrishnan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial
Selina R. Cox et al.
GASTROENTEROLOGY (2020)
Antibiotic Cocktail for Pediatric Acute Severe Colitis and the Microbiome: The PRASCO Randomized Controlled Trial
Dan Turner et al.
INFLAMMATORY BOWEL DISEASES (2020)
A randomized controlled trial investigating the effect of a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols on the intestinal microbiome and inflammation in patients with ulcerative colitis: study protocol for a randomized controlled trial
Alireza Milajerdi et al.
TRIALS (2020)
Fecal microbiota transplantation to maintain remission in Crohn's disease: a pilot randomized controlled study
Harry Sokol et al.
MICROBIOME (2020)
Difference in Pathomechanism Between Crohn's Disease and Ulcerative Colitis Revealed by Colon Transcriptome (vol 25, izy359, 2019)
Lili Yang et al.
INFLAMMATORY BOWEL DISEASES (2019)
Neurotrophic factor GDNF regulates intestinal barrier function in inflammatory bowel disease
Michael Meir et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Bifidobacterium dentium Fortifies the Intestinal Mucus Layer via Autophagy and Calcium Signaling Pathways
Melinda A. Engevik et al.
MBIO (2019)
Functions and regulation of T cell-derived interleukin-10
Christian Neumann et al.
SEMINARS IN IMMUNOLOGY (2019)
Microbiota and mucosal defense in IBD: an update
Eduard F. Stange et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2019)
NOD1 and NOD2 in inflammation, immunity and disease
Tapas Mukherjee et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2019)
Mucosal Healing and Bacterial Composition in Response to Enteral Nutrition Vs Steroid-based Induction Therapy-A Randomised Prospective Clinical Trial in Children With Crohn's Disease
Benedicte Pigneur et al.
JOURNAL OF CROHNS & COLITIS (2019)
NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease
T. Schwerd et al.
MUCOSAL IMMUNOLOGY (2018)
Hypermethylation of IL-10 gene is responsible for its low mRNA expression in Behcet's disease
Shahriar Alipour et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Mutations in Interleukin-10 Receptor and Clinical Phenotypes in Patients with Very Early Onset Inflammatory Bowel Disease: A Chinese VEO-IBD Collaboration Group Survey
Zhiheng Huang et al.
INFLAMMATORY BOWEL DISEASES (2017)
C4B gene influences intestinal microbiota through complement activation in patients with paediatric-onset inflammatory bowel disease
E. Nissilae et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2017)
Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials
A. Cholapranee et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases
Ulrike Billmeier et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Glial cell line-derived neurotrophic factor promotes barrier maturation and wound healing in intestinal epithelial cells in vitro
Michael Meir et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2015)
MicroRNA signatures differentiate Crohn's disease from ulcerative colitis
Jeremy S. Schaefer et al.
BMC IMMUNOLOGY (2015)
Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial
Paul Moayyedi et al.
GASTROENTEROLOGY (2015)
Matrix Metalloproteinases in Inflammatory Bowel Disease: An Update
Shane O'Sullivan et al.
MEDIATORS OF INFLAMMATION (2015)
NOD1 and NOD2: Signaling, Host Defense, and Inflammatory Disease
Roberta Caruso et al.
IMMUNITY (2014)
The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system
Thaher Pelaseyed et al.
IMMUNOLOGICAL REVIEWS (2014)
Mechanisms That Mediate the Development of Fibrosis in Patients With Crohn's Disease
Chao Li et al.
INFLAMMATORY BOWEL DISEASES (2014)
Very early-onset inflammatory bowel disease (IBD) in infancy is a different disease entity from adult-onset IBD; one form of interleukin-10 receptor mutations
Jung Ok Shim et al.
JOURNAL OF HUMAN GENETICS (2014)
Inflammatory bowel disease: Pathogenesis
Yi-Zhen Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Correlation of MMP-3 and MMP-9 with Crohn's Disease Activity in Children
Anna Kofla-Dlubacz et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
Interleukin (IL)-23 Suppresses IL-10 in Inflammatory Bowel Disease
Zhanju Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease
Luke Jostins et al.
NATURE (2012)
IL-12 family cytokines: immunological playmakers
Dario A. A. Vignali et al.
NATURE IMMUNOLOGY (2012)
IL-10 and IL-10 receptor defects in humans
Erik-Oliver Glocker et al.
YEAR IN HUMAN AND MEDICAL GENETICS: INBORN ERRORS OF IMMUNITY II (2011)
Epidemiology and Natural History of Inflammatory Bowel Diseases
Jacques Cosnes et al.
GASTROENTEROLOGY (2011)
The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions
Malin E. V. Johansson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A role for Campylobacter jejuni-induced enteritis in inflammatory bowel disease?
Lisa D. Kalischuk et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)
ATG16L1 and NOD2 Interact in an Autophagy-Dependent Antibacterial Pathway Implicated in Crohn's Disease Pathogenesis
Craig R. Homer et al.
GASTROENTEROLOGY (2010)
IL-23 and Autoimmunity: New Insights into the Pathogenesis of Inflammatory Bowel Disease
Clara Abraham et al.
ANNUAL REVIEW OF MEDICINE (2009)
Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease
S. Brand
GUT (2009)
IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease
T. Kobayashi et al.
GUT (2008)
Development, cytokine profile and function of human interleukin 17-producing helper T cells
Nicholas J. Wilson et al.
NATURE IMMUNOLOGY (2007)
Fibrogenesis in Crohn's disease
John P. Burke et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Matrix metalloproteinases as profibrotic factors in terminal ileum in Crohn's disease
Nienke Warnaar et al.
INFLAMMATORY BOWEL DISEASES (2006)
Role of matrix metalloproteinases in intestinal inflammation
Carlos Medina et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Muc2-deficient mice spontaneously develop colitis, indicating that Muc2 is critical for colonic protection
Maria Van der Sluis et al.
GASTROENTEROLOGY (2006)
Reduced Paneth cell α-defensins in ileal Crohn's disease
J Wehkamp et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Murarnyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease
DA van Heel et al.
LANCET (2005)
Expression and regulation of tissue inhibitor of metalloproteinase-1 and matrix metalloproteinases by intestinal myofibroblasts in inflammatory bowel disease
BC McKaig et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Host recognition of bacterial muramyl dipeptide mediated through NOD2
N Inohara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
JP Hugot et al.
NATURE (2001)
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Y Ogura et al.
NATURE (2001)
Transfer of interleukin-4 and interleukin-10 in patients with severe inflammatory bowel disease of the rectum
MA Rogy et al.
HUMAN GENE THERAPY (2000)
Share Paper
